Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
Early Phase Clinical Research
Learn More About Medical Research

Get the news first! Sign-up to receive e-mail updates on new studies that are enrolling volunteers.

First Name:  
Last Name:  
Email:    
   
   



Address

5355 Medpace Way
Cincinnati, Ohio 45227
Directions
513.366.3222
866.872.2349
Email us Download our contact info straight to your phone.



Do you know of someone else who may be interested in participating in a trial? When your friend completes their first research study with Medpace, you will receive $100. Download the Medpace Refer a Friend Card.

We are currently looking for patients with Osteoarthritis and Rheumatoid Arthritis. Learn more about enrolling in arthritis studies here or refer a friend and earn $100.

Stay Connected

"Like" us on Facebook to stay up-to-date on new studies that are enrolling.

Like Medpace on Facebook to stay up-to-date on enrolling studies

Before a new medication or procedure can be introduced to the public, it must undergo a series of rigorous studies to prove that it is safe and effective to use in people. Following the successful completion of these studies in the United States, the medicine or procedure is submitted to the Food and Drug Administration (FDA) for approval (in other countries, applications are assessed by regulatory authorities similar to the FDA.

There are four basic steps or phases of research that a drug or procedure must go through. Specific information is gathered in each phase, and that information determines how to approach research at the next phase. The Medpace Clinical Pharmacology Unit conducts Phase I and Phase IIa studies, which are well-controlled studies where participants stay at our comfortable, centrally located facility overnight or for a series of days.

  1. Phase I is the study of the drug or procedure in normal, healthy volunteers.
  2. Phase II is the study of the drug or procedure in small groups of patients with the targeted disease.

By providing valuable information on how the drug or procedure affects the body, what side effects may be seen, and what the correct dosage may be, these phases together answer the important questions:

  • Is the drug or procedure safe to give to humans?
  • Does the drug or procedure work in humans?

Before a study can be started a study protocol must be written to outline the processes and procedures the study must follow, with a focus on patient safety and scientific accuracy. The protocol outlines the history of the drug or device, why the study is needed, exactly what will happen in the study, the rules about who may or may not qualify for the study, and what medical measurements will be reviewed.

The key person conducting the study is a medical doctor known as the Principal Investigator (PI). This person, who you will meet and interact with, is responsible for making sure the study adheres to the protocol while protecting your safety and well-being.

The PI is aided in this process by an independent oversight body known as the Institutional Review Board (IRB), made up of scientific experts, physicians, ethicists, lay persons, and possibly others from the community. The IRB's purpose is to make sure the study is needed, conducted in an ethical manner and that the rights of the study participants are protected.